Merck Will Allow Other Drug Manufacturers to Produce Its COVID-19 Pill

(LONDON) —Pharmaceutical company Merck agreed to allow other drug makers to produce its COVID-19 pill, in a move aimed at helping millions of people in poorer countries get access to the potentially life-saving drug, a United Nations-backed public health organization said on Wednesday. The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. The agreement will allow the Medicines Patent Pool to grant further licenses to qualified companies who are approved to make the drug. Neither drug maker will receive royalties under the agreement for as long as the World Health Organization deems COVID-19 to be global emergency. Molnupiravir is the first pill that has been shown to treat the disease. [time-brightcove not-tgx=”true”] Charles Gore, the executive director of the Medicines Patent Pool, said the early results for molnupiravir were “compelling” and that he hoped this first voluntary licensing agreement for a COVID-19 treatment would lead to others. Despite repeated requests from governments and health officials, no vaccine makers have agreed to a similar deal. A hub set up by WHO in South Africa intended to share messenger RNA vaccine recipes and technologies has not enticed a single pharmaceutical to join. Merck has requested its pill be licensed by both the U.S. Food and Drug Administration and the European Medicines Agency, decisions t...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Related Links:

The current Coronavirus disease 2019 (COVID-19) pandemic has become a global challenge, and although vaccines have been developed, it is expected that mild to moderate patients will control their symptoms, especially in developing countries. Licorice, not only a food additive, but also a common traditional Chinese herbal medicine, which has several pharmacological effects, such as anti-inflammation, detoxification, antibacterial, antitussive, and immunomodulatory effects, especially in respiratory diseases. Since the outbreak of COVID-19, glycyrrhizin, glycyrrhizin diamine and glycyrrhizin extract have been widely studied ...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
AbstractPurpose of ReviewTo introduce readers to policy modeling, a multidisciplinary field of quantitative analysis, primarily used to help guide decision-making. This review focuses on the choices facing educational administrators, from K-12 to universities in the USA, as they confronted the COVID-19 pandemic. We survey three key model-based approaches to mitigation of SARS-CoV-2 spread in schools and on university campuses.Recent FindingsFrequent testing, coupled with strict attention to behavioral interventions to prevent further transmission can avoid large outbreaks on college campuses. K-12 administrators can greatl...
Source: Current HIV/AIDS Reports - Category: Infectious Diseases Source Type: research
Conclusion: Pandemic of coronavirus infection has influence of very high vaccination rate among all COPD patients.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research
Conclusions: Following legislation of sanitary measures for the COVID-19 pandemic in Portugal, increased rates of positive tuberculosis screenings were contrasted by a decrease in the diagnoses of LT, which may reflect a collateral protective effect on the rates of tuberculosis infection.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Tuberculosis and non-tuberculous mycobacterial diseases Source Type: research
Reumatismo. 2021 Nov 22;73(3). doi: 10.4081/reumatismo.2021.1445.ABSTRACTSince the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 v...
Source: Reumatismo - Category: Rheumatology Authors: Source Type: research
The private sector and some government agencies have demanded that staff vaccinate, especially in the tourism industry that drives many regional economies. Credit: Zadie Neufville/IPSBy Zadie NeufvilleKINGSTON, Nov 22 2021 (IPS) When face-to-face Cabinet meetings resumed in Jamaica following more than a year of virtual meetings due to COVID-19, Ministers lined up to have their immunisation cards inspected. Prime Minister Andrew Holness said the Government “has to lead the country towards normality”. “The way to do it is for every Jamaican to comply with the infection, prevention and control measures tha...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: COVID-19 COVID-19 VACCINES Development & Aid Economy & Trade Featured Financial Crisis Headlines Health Latin America & the Caribbean TerraViva United Nations Trade & Investment Source Type: news
Rzymski The response to the pandemic requires access to accurate information and public understanding and adherence to preventive measures. This online cross-sectional study of adult Poles (n = 1337) assessed the frequency of COVID-19 preventive behaviors, fears related to the COVID-19 pandemic, and beliefs in COVID-19-related conspiracy theories during the early phase of the COVID-19 pandemic when the nationwide lockdown was imposed (April 2020). As shown, 22% of surveyed admitted not to wash their hands frequently, while 12% did not use disinfectants. These two behaviors were also less frequent in individuals with me...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
Conclusions: Detectable levels of SARS-CoV-2-specific antibodies persist up to 13 months after infection for the majority of the cases.
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research
(LONDON) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. The deal excludes some large countries that have suffered devastating coronavirus outbreaks. For example, while a...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The 2019 outbreak of coronavirus disease (COVID-19) in Wuhan (Hubei province of China) has given rise to a pandemic spread of virus, more than 240 million incidences and a death toll larger than 5 million people. COVID-19 has set off large efforts in research, therapy and patient care, as well as public and private debates in every imaginable form. A number of scientists used the publication platforms provided by the Federation of the European Biochemical Societies (FEBS) to present their research data, reviews, opinions and other contributions relating to COVID-19 and severe acute respiratory syndrome coronavirus 2 (SARS-...
Source: FEBS Letters - Category: Biochemistry Authors: Tags: Commentary Source Type: research
More News: African Health | Brazil Health | China Health | COVID-19 | Emergency Medicine | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Grants | Health | Health Management | Hospitals | International Medicine & Public Health | Legislation | Merck | Outbreaks | Pandemics | South Africa Health | United Nations | Vaccines | WHO